Aisling Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8
- Investments
-
245
- Portfolio
-
8
- Exits
-
169
Aisling Capital General Information
Company Description
Founded in 2000, Aisling Capital is a venture capital firm based in New York. The firm seeks to invest in healthcare and life science sectors based in Canada, Europe & American regions. This firm is a Registered Investment Adviser (RIA).
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 489 Fifth Avenue
- Floor 10
- New York, NY 10017
- United States
Aisling Capital Investments & Acquisitions (245)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Dren Bio | 29-Oct-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Claris Bio | 24-Jul-2026 | Biotechnology | Clinical Trials - General | |||
| Allotera Therapeutics | 08-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Treeline Biosciences Holdings | 01-Sep-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Marker Therapeutics | 19-Dec-2024 | Biotechnology | Generating Revenue | |||
| GondolaBio | 16-Aug-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| BridgeBio Oncology Therapeutics | 30-Apr-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Mindful Health Solutions | 01-Jan-2024 | Clinics/Outpatient Services | Generating Revenue | |||
| Bicara Therapeutics | 06-Dec-2023 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| COMPASS Pathways | 18-Aug-2023 | PIPE | Biotechnology | Generating Revenue |
Aisling Capital Exits (169)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Mindful Health Solutions | 01-Jun-2026 | Merger/Acquisition | |
| COMPASS Pathways | 20-Feb-2026 | ||
| BridgeBio Oncology Therapeutics | 11-Aug-2025 | ||
| Stratus Therapeutics | 04-Mar-2025 | ||
| Poseida Therapeutics | 08-Jan-2025 | ||
| Prolacta Bioscience | 30-Dec-2024 | ||
| HerbalScience Group | 02-Nov-2024 | ||
| OnKure Therapeutics | 04-Oct-2024 | ||
| Reneo Pharmaceuticals | 04-Oct-2024 | Merger/Acquisition | |
| Bicara Therapeutics | 13-Sep-2024 | IPO |
Aisling Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Aisling Capital Investments by Industry, Year, and Region
Aisling Capital Co-Investors (74)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 3 |
|
|
||
| OrbiMed |
|
|
|||
| Deerfield Management |
|
|
|||
| GV |
|
|
|||
| Omega Funds |
|
|
Aisling Capital FAQs
-
What is Aisling Capital?
Founded in 2000, Aisling Capital is a venture capital firm based in New York.
-
When was Aisling Capital founded?
Aisling Capital was founded in 2000.
-
Where is Aisling Capital headquartered?
Aisling Capital is headquartered in New York, NY.
-
What is Aisling Capital's total asset value?
Aisling Capital has around in total assets under management.
-
How many investments has Aisling Capital made?
Aisling Capital has made 245 investments.
-
What has Aisling Capital invested in?
Aisling Capital has made numerous investments in companies like Dren Bio, Claris Bio, and Allotera Therapeutics within the Drug Discovery and Biotechnology industries.
-
What has Aisling Capital invested in recently?
Aisling Capital's latest investment was on 29-Oct-2026 in Dren Bio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process